- Filed
- May 22, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 7M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 6.94M sh |
| Shares Outstanding | Q1 2026 · Mar 31, 2026 | 7M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$349.69K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$404.09K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $11.71K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $236.4K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$2.84M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$1.96M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$76.23K |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $409.61K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $3.03M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.41M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.04M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.45M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $50.63K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $305.39K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $196.34K |
| Total Assets | Q1 2026 · Dec 31, 2025 | $481.6K |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.20 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.15 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.20 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.15 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $703.44K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $371.75K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $182.15K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $169.7K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$923.29K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$539.62K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$886.75K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$542.61K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $507.29K |